Comprehensive overview: efficacy, tolerability, and cost-effectiveness of clobazam in Lennox–Gastaut syndrome
Michele A Faulkner1,21Department of Pharmacy Practice, Creighton University School of Pharmacy, 2Department of Neurology, Creighton University School of Medicine, Omaha, NE, USAAbstract: Clobazam is the newest medication approved by the US Food and Drug Administration (FDA) for the...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-06-01
|
| Series: | Therapeutics and Clinical Risk Management |
| Online Access: | http://www.dovepress.com/comprehensive-overview-efficacy-tolerability-and-cost-effectivene-peer-reviewed-article-TCRM |